Stricklett P K, Nelson R D, Kohan D E
Salt Lake Veterans Affairs Medical Center and University of Utah, Salt Lake City, Utah 84148, USA.
Exp Nephrol. 1999 Jan-Feb;7(1):67-74. doi: 10.1159/000020587.
The aquaporin-2 promoter has been used to drive Cre recombinase expression in order to achieve renal collecting duct principal cell specific gene deletion. This technique requires two lines of mice: one transgenic mouse line containing a cell-specific promoter driving Cre recombinase expression and the other line, engineered using gene targeting strategies, that contains a lox-flanked target gene of interest. Mating of these two mouse lines permits cell-specific deletion of the target gene. This method could ultimately be used to obtain targeted deletion of any gene in any cell type in the kidney for which a specific promoter has been identified. The applications of this technology, as well as its strengths and weaknesses, are discussed with particular reference to the kidney.
水通道蛋白-2启动子已被用于驱动Cre重组酶表达,以实现肾集合管主细胞特异性基因缺失。该技术需要两种品系的小鼠:一种转基因小鼠品系,其包含驱动Cre重组酶表达的细胞特异性启动子;另一种品系是利用基因靶向策略构建的,其包含感兴趣的lox侧翼靶基因。将这两种品系的小鼠进行交配可实现靶基因的细胞特异性缺失。该方法最终可用于在已鉴定出特定启动子的肾脏任何细胞类型中获得任何基因的靶向缺失。本文特别参考肾脏讨论了该技术的应用及其优缺点。